Translational Orthopedics: Handbook for Designing and Conducting Clinical and Translational Research
Editat de Jeffrey A. Bakal, Jack M. Haglin, Joseph Abboud, Joseph J. Crisco, Adam E.M. Eltoraien Limba Engleză Paperback – 18 apr 2024
The practical, straightforward approach helps the aspiring investigator navigate challenging considerations in study design and implementation. The book provides valuable discussions of the critical appraisal of published studies in translational orthopedics, allowing the reader to learn how to evaluate the quality of such studies with respect to measuring outcomes and to make effective use of all types of evidence in patient care. In short, this practical guidebook will be of interest to every Medical Researcher or Orthopedist who has ever had a good clinical idea but not the knowledge of how to test it.
- Focuses on the principles of evidence-based medicine and applies these principles to the design of translational investigations within orthopedics
- Provides a practical, straightforward approach that helps investigators navigate challenging considerations in study design and implementation
- Details discussions of the critical appraisal of published studies in translational orthopedics, supporting evaluation with respect to measuring outcomes and making effective use of all types of evidence in patient care
Preț: 753.09 lei
Preț vechi: 973.13 lei
-23% Nou
Puncte Express: 1130
Preț estimativ în valută:
144.11€ • 148.90$ • 119.88£
144.11€ • 148.90$ • 119.88£
Carte tipărită la comandă
Livrare economică 13-27 martie
Livrare express 12-18 februarie pentru 113.91 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780323856638
ISBN-10: 0323856632
Pagini: 578
Dimensiuni: 216 x 276 x 30 mm
Greutate: 1.52 kg
Editura: ELSEVIER SCIENCE
Seria Handbook for Designing and Conducting Clinical and Translational Research
ISBN-10: 0323856632
Pagini: 578
Dimensiuni: 216 x 276 x 30 mm
Greutate: 1.52 kg
Editura: ELSEVIER SCIENCE
Seria Handbook for Designing and Conducting Clinical and Translational Research
Cuprins
Preface
Adam E. M. Eltorai
Introduction
1. Introduction
2. Translational Process
3. Scientific Method
4. Basic research
PRE-CLINCIAL
5. Overview of Preclinical Research
6. What Problem are you Solving?
7. Types of Interventions
8. Drug discovery
9. Drug Testing
10. Device discovery and prototyping
11. Device testing
12. Diagnostic Discovery
13. Diagnostic Testing
14. Other Product Types
15. Procedural Technique Development
16. Behavioral Intervention
CLINICAL: FUNDAMENTALS
17. Introduction to clinical research
18. The question
19. Study population
20. Outcome measurements
21. Optimizing the question
STATISTICAL PRINCIPLES
22. Common issues in analysis
23. Basic statistical principles
24. Distributions
25. Hypotheses and error types
26. Power
27. Regression
28. Continuous variable analyses
29. Categorical variable analyses
30. Analysis of variance
31. Correlation
32. Biases
33. Basic science statistics
CLINICAL: STUDY TYPES
34. Design principles
35. Case series
36. Case-control study
37. Cohort study
38. Cross-section study
39. Longitudinal Study
40. Clinical trials
41. Meta-analysis
42. Cost effectiveness study
43. Diagnostic test evaluation
44. Reliability study
45. Database studies
46. Surveys and questionnaires
47. Qualitative methods and mixed methods
CLINICAL TRIALS
48. Randomized control
49. Nonrandomized control
50. Historical control
51. Cross-over
52. Withdrawal studies
53. Factorial design
54. Group allocation
55. Hybrid design
56. Large, pragmatic
57. Adaptive
58. Randomization
59. Blinding
60. Multicenter considerations
61. Registries
62. Phases of Clinical Trials
63. IDEAL Framework
64. Artificial Intelligence
65. Patient Perspectives
CLINICAL: PREPARATION
66. Sample size
67. Budgeting
68. Ethics and review boards
69. Regulatory considerations for new drugs and devices
70. Funding approaches
71. Subject recruitment
72. Data management
74. Statistical Software
75. Report forms
76. Subject adherence
77. Survival analysis
78. Monitoring committee in clinical trials
REGULATORY BASICS
79. FDA Overview
80. IND
81. New drug application
82. Devices
83. Radiation-emitting Electronic Products
84. Orphan Drugs
85. Biologics
86. Combination Productions
87. Foods
88. Cosmetics
89. CMC and GxP
90. Non-US regulatory
91. Post-market drug safety monitoring
92. Post-market device safety monitoring
CLINICAL IMPLEMENTATION
93. Implementation Research
94. Design and Analysis
95. Mixed Methods Research
96. Population- and setting-specific implementation
PUBLIC HEALTH
97. Public Health
98. Epidemiology
99. Factors
100. Good questions
101. Population- and environmental-specific considerations
102. Law, policy, and ethics
103. Healthcare institutions and systems
104. Public health institutions and systems
Practical Resources
105. Presenting data
106. Manuscript preparation
107. Building a team
108. Patent basics
109. Venture pathways
110. SBIR/STTR
111. Sample forms and templates
Adam E. M. Eltorai
Introduction
1. Introduction
2. Translational Process
3. Scientific Method
4. Basic research
PRE-CLINCIAL
5. Overview of Preclinical Research
6. What Problem are you Solving?
7. Types of Interventions
8. Drug discovery
9. Drug Testing
10. Device discovery and prototyping
11. Device testing
12. Diagnostic Discovery
13. Diagnostic Testing
14. Other Product Types
15. Procedural Technique Development
16. Behavioral Intervention
CLINICAL: FUNDAMENTALS
17. Introduction to clinical research
18. The question
19. Study population
20. Outcome measurements
21. Optimizing the question
STATISTICAL PRINCIPLES
22. Common issues in analysis
23. Basic statistical principles
24. Distributions
25. Hypotheses and error types
26. Power
27. Regression
28. Continuous variable analyses
29. Categorical variable analyses
30. Analysis of variance
31. Correlation
32. Biases
33. Basic science statistics
CLINICAL: STUDY TYPES
34. Design principles
35. Case series
36. Case-control study
37. Cohort study
38. Cross-section study
39. Longitudinal Study
40. Clinical trials
41. Meta-analysis
42. Cost effectiveness study
43. Diagnostic test evaluation
44. Reliability study
45. Database studies
46. Surveys and questionnaires
47. Qualitative methods and mixed methods
CLINICAL TRIALS
48. Randomized control
49. Nonrandomized control
50. Historical control
51. Cross-over
52. Withdrawal studies
53. Factorial design
54. Group allocation
55. Hybrid design
56. Large, pragmatic
57. Adaptive
58. Randomization
59. Blinding
60. Multicenter considerations
61. Registries
62. Phases of Clinical Trials
63. IDEAL Framework
64. Artificial Intelligence
65. Patient Perspectives
CLINICAL: PREPARATION
66. Sample size
67. Budgeting
68. Ethics and review boards
69. Regulatory considerations for new drugs and devices
70. Funding approaches
71. Subject recruitment
72. Data management
74. Statistical Software
75. Report forms
76. Subject adherence
77. Survival analysis
78. Monitoring committee in clinical trials
REGULATORY BASICS
79. FDA Overview
80. IND
81. New drug application
82. Devices
83. Radiation-emitting Electronic Products
84. Orphan Drugs
85. Biologics
86. Combination Productions
87. Foods
88. Cosmetics
89. CMC and GxP
90. Non-US regulatory
91. Post-market drug safety monitoring
92. Post-market device safety monitoring
CLINICAL IMPLEMENTATION
93. Implementation Research
94. Design and Analysis
95. Mixed Methods Research
96. Population- and setting-specific implementation
PUBLIC HEALTH
97. Public Health
98. Epidemiology
99. Factors
100. Good questions
101. Population- and environmental-specific considerations
102. Law, policy, and ethics
103. Healthcare institutions and systems
104. Public health institutions and systems
Practical Resources
105. Presenting data
106. Manuscript preparation
107. Building a team
108. Patent basics
109. Venture pathways
110. SBIR/STTR
111. Sample forms and templates